{"id":12199,"date":"2008-04-21T10:30:00","date_gmt":"2008-04-21T08:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/rassegna-stampa-farmaceutica-dal-18-al-21-aprile-di-aboutpharma\/"},"modified":"2008-04-21T10:30:00","modified_gmt":"2008-04-21T08:30:00","slug":"rassegna-stampa-farmaceutica-dal-18-al-21-aprile-di-aboutpharma","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/rassegna-stampa-farmaceutica-dal-18-al-21-aprile-di-aboutpharma\/","title":{"rendered":"PHARMACEUTICAL PRESS REVIEW from 18 to 21 April of AboutPharma"},"content":{"rendered":"

Press Review from<\/span><\/font><\/strong><\/strong> 18\/04\/08<\/span><\/font><\/strong><\/strong><\/span><\/strong> to the<\/span><\/font><\/strong><\/strong> 21\/04\/08<\/span><\/font><\/strong><\/strong><\/span><\/strong> <\/p>\n

<\/span><\/font><\/p>\n

<\/p>\n

<\/span><\/font><\/strong><\/p>\n

"Bayer can race again"<\/p>\n

<\/span><\/font><\/strong><\/p>\n

(the Business Republic<\/personname> & Finance: p. 22 \u2013 21 April 2008)<\/p>\n

<\/span><\/font><\/p>\n

2008 didn't start well for Bayer, but Credit Suisse believes the German company has all the potential for a recovery. Analysts explain that 'in the first 3 months of the year, prices followed the decline of the German market. The cause must be sought in the negative developments in the healthcare sector and in the cyclical nature of the chemical sector'. For these reasons, the shares suffered a depreciation of approximately 20%. The German broker expects that a boost to the shares will come from an increase in profits, higher than estimates.<\/p>\n

<\/span><\/font><\/p>\n

http:\/\/www.aboutpharma.it\/notizia.asp?id=16455<\/a><\/p>\n

<\/span><\/font><\/p>\n

<\/p>\n

 <\/p>\n

<\/span><\/font><\/p>\n

The 1st quarter was positive for Novartis<\/p>\n

<\/span><\/font><\/strong><\/p>\n

(Les Echos online \u2013 April 21, 2008)<\/p>\n

<\/span><\/font><\/p>\n

In the 1st quarter 2008, the<\/metricconverter>Novartis net income increased 10% to $2.3 billion and revenue increased 8.6% to $9.9 billion.<\/p>\n

<\/span><\/font><\/p>\n

http:\/\/www.aboutpharma.it\/notizia.asp?id=16452<\/a><\/p>\n

<\/span><\/font><\/p>\n

<\/p>\n

 <\/p>\n

<\/span><\/font><\/p>\n

"Council of State. Chemotherapy also in clinics, a regional resolution suspended"<\/p>\n

<\/span><\/font><\/s\n<\/p>","protected":false},"excerpt":{"rendered":"

Rassegna Stampa dal 18\/04\/08 al 21\/04\/08  "Bayer può tornare a correre" (la Repubblica Affari & Finanza: pag. 22 – 21 aprile 2008) Il 2008 non è iniziato bene per Bayer, ma Credit Suisse ritiene che l’azienda tedesca abbia tutte le carte in regola per una ripresa. Gli analisti spiegano che ‘nei primi 3 mesi dell’anno le quotazioni …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-12199","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/12199","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=12199"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/12199\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=12199"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=12199"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=12199"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}